HomeInsightsPE

Auro Laboratories Ltd P/E Ratio

Auro Laboratories Ltd P/E Ratio

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

4.2 K

stocks traded

Last Updated time: 25 Jul 12:46 PM

Image

Auro Laboratories Ltd

NSE: AUROLABS

PE

14.1

Last updated : 25 Jul 12:46 PM

Key Highlights

    The P/E Ratio of Auro Laboratories Ltd is 14.1 as of 25 Jul 12:46 PM .a1#The P/E Ratio of Auro Laboratories Ltd changed from 8.4 on March 2019 to 12.9 on March 2024 . This represents a CAGR of 7.41% over 6 years. a1#The Latest Trading Price of Auro Laboratories Ltd is ₹ 172.7 as of 25 Jul 12:35 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.3 to 27.3 in 5 years. This represents a CAGR of -0.72%a1# The PE Ratio of Automobile industry is 18.9. The PE Ratio of Finance industry is 23.5. The PE Ratio of IT - Software industry is 29.1. The PE Ratio of Pharmaceuticals industry is 38.6. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 24.3. In 2024a1#The Market Cap of Auro Laboratories Ltd changed from ₹ 37.04 crore on March 2019 to ₹ 100.4 crore on March 2024 . This represents a CAGR of 18.08% over 6 years. a1#The Revenue of Auro Laboratories Ltd changed from ₹ 11.24 crore to ₹ 12.46 crore over 8 quarters. This represents a CAGR of 5.29% a1#The EBITDA of Auro Laboratories Ltd changed from ₹ 0.63 crore to ₹ 2.81 crore over 8 quarters. This represents a CAGR of 111.19% a1#The Net Pr of Auro Laboratories Ltd changed from ₹ 0.08 crore to ₹ 2.32 crore over 8 quarters. This represents a CAGR of 438.52% a1#The Dividend Payout of Auro Laboratories Ltd changed from 0 % on March 2019 to 0 % on March 2024 . This represents a CAGR of 0.0% over 6 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Auro Laboratories Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Auro Laboratories Ltd

Period
Mar '198.4
Mar '204.8
Mar '217
Mar '2222
Mar '2313.9
Mar '2412.9

Company Fundamentals for Auro Laboratories Ltd

Market Cap

109 Cr

EPS

12.5

P/E Ratio (TTM) *

14.1

P/B Ratio (TTM) *

2.6

Day’s High

178.0

Day’s Low

168.75

DTE *

0.6

ROE *

18.6

52 Week High

307.2

52 Week Low

75.12

ROCE *

16.2

* All values are consolidated

Last Updated time: 25 Jul 12:46 PM

* All values are consolidated

Last Updated time: 25 Jul 12:46 PM

Image

Auro Laboratories Ltd

NSE: AUROLABS

PRICE

172.7

-3.35 (-1.90%)

stock direction

Last updated : 25 Jul 12:35

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Auro Laboratories Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Auro Laboratories Ltd

Market Value

110

Asset Value

31

2.6 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Auro Laboratories Ltd14109
Sun Pharmaceuticals Industries Ltd38388,632
Cipla Ltd28121,443
Divis Laboratories Ltd75120,718
Zydus Lifesciences Ltd30118,680
Dr Reddys Laboratories Ltd20113,730

Key Valuation Metric of Auro Laboratories Ltd

Earnings

7 Cr

14.1 X

PE Ratio

Market Cap

₹109.68Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

7 Cr

14.1 X

PE Ratio

Market Cap

₹109.68Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Auro Laboratories Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Auro Laboratories Ltd

Period
Mar '1937
Mar '2020
Mar '2151
Mar '2262
Mar '2334
Mar '24100

* All values are a in crore

×

Historical Revenue of Auro Laboratories Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Auro Laboratories Ltd

Period
Jun '2211
Sep '2212
Dec '2216
Mar '2314
Jun '2311
Sep '2314
Dec '2318
Mar '2412

* All values are a in crore

×

Historical EBITDA of Auro Laboratories Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Auro Laboratories Ltd

Period
Jun '221
Sep '221
Dec '221
Mar '233
Jun '232
Sep '233
Dec '235
Mar '243

* All values are a in crore

×

Historical Net Profit of Auro Laboratories Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Auro Laboratories Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '232
Jun '231
Sep '232
Dec '233
Mar '242

* All values are a in crore

×

Historical Dividend Payout of Auro Laboratories Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Auro Laboratories Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230
Mar '240

* All values are a in %

About Auro Laboratories Ltd

About Auro Laboratories Ltd

    Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra. The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for API's and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum. Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom. The Company received ISO 9001:2000 and WHO - cGMPs certification. It also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.

Auro Laboratories Ltd News Hub

News

Auro Laboratories to hold AGM

Auro Laboratories announced that the 35th Annual General Meeting (AGM) of the company will...

Read more

31 May 202416:59

News

Auro Laboratories to table results

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 25 May 2...

Read more

18 May 202417:29

News

Auro Laboratories to declare Quarterly Result

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 6 Februa...

Read more

01 Feb 202420:32

News

Auro Laboratories to table results

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 9 Novemb...

Read more

06 Nov 202315:29

News

Auro Laboratories to hold AGM

Auro Laboratories announced that the 34th Annual General Meeting (AGM) of the company will...

Read more

01 Sep 202312:55

News

Auro Laboratories to conduct board meeting

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 31 July ...

Read more

22 Jul 202312:23

Product Composition by Percentage (Revenue)

FAQs for PE of Auro Laboratories Ltd

What is Auro Laboratories Ltd current share price?

The current market price of Auro Laboratories Ltd as of July 25, 2024 is ₹172.70.

What is Auro Laboratories Ltd's market cap?

Auro Laboratories Ltd's market capitalisation stood at ₹109 Cr as of July 25, 2024

What are Auro Laboratories Ltd's total net assets?

According to Auro Laboratories Ltd's most recent financial filings, the company's net assets total ₹30.9 Cr.

Is Auro Laboratories Ltd making a profit or loss?

Auro Laboratories Ltd's net Profit as of July 25, 2024 is close to ₹7 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199